Telescope Innovations Corp. (CSE:TELI)
Canada · Delayed Price · Currency is CAD 0.3650
+0.0750 (20.55%)
Jul 18, 2025, 3:59 PM EDT
Telescope Innovations Company Description
Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.
The company has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide.
Telescope Innovations Corp. is based in Vancouver, Canada.
Telescope Innovations Corp.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Henry Dubina |
Contact Details
Address: 301 - 2386 East Mall Vancouver, British Columbia V6T 1Z3 Canada | |
| Phone | 778 262 1166 |
| Website | telescopeinnovations.com |
Stock Details
| Ticker Symbol | TELI |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | September - August |
| Reporting Currency | CAD |
| ISIN Number | CA87953P1080 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Henry Dubina | Chief Executive Officer and Chairman of Board |
| Prof. Jason Hein | Chief Technology Officer and Director |
| John Kirincic | Chief Financial Officer |
| Dr. Jeffrey W. Sherman Ph.D. | Chief Operating Officer |
| Shad Grunert | Senior Vice President of Sales and Marketing |
| Deborah Cotter | Company Secretary |